Free Trial

SELLAS Life Sciences Group (SLS) Insider Trading & Ownership

SELLAS Life Sciences Group logo
$1.66 +0.01 (+0.61%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$1.72 +0.06 (+3.31%)
As of 06/13/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SELLAS Life Sciences Group (NASDAQ:SLS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.40%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$48.60K
Number Of
Insiders Selling
(Last 12 Months)
0
Get SLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling SELLAS Life Sciences Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SLS Insider Buying and Selling by Quarter

SELLAS Life Sciences Group Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/12/2025Nostrand Robert L VanDirectorBuy10,000$1.48$14,800.00  
5/30/2025Jane WasmanDirectorBuy20,000$1.69$33,800.00  
(Data available from 1/1/2013 forward)

SLS Insider Trading Activity - Frequently Asked Questions

The list of insiders at SELLAS Life Sciences Group includes Jane Wasman, and Nostrand Robert L Van. Learn more on insiders at SLS.

1.40% of SELLAS Life Sciences Group stock is owned by insiders. Learn more on SLS's insider holdings.

The following insiders have purchased SLS shares in the last 24 months: Jane Wasman ($33,800.00), and Nostrand Robert L Van ($14,800.00).

Insiders have purchased a total of 30,000 SLS shares in the last 24 months for a total of $48,600.00 bought.

SELLAS Life Sciences Group Key Executives

  • Dr. Angelos M. Stergiou M.D. (Age 48)
    ScD h.c., Founder, President, CEO & Director
    Compensation: $904.24k
  • Mr. John Thomas Burns CPA (Age 39)
    Senior VP & CFO
    Compensation: $505.16k
  • Ms. Stacy E. Yeung
    VP, Associate General Counsel & Head of Compliance
  • Dr. Dragan Cicic M.D. (Age 61)
    MBA, Senior Vice President of Clinical Development
    Compensation: $466.43k
  • Mr. Andrew Elnatan
    VP and Head of Regulatory Affairs, Chemistry, Manufacturing and Controls & Quality


This page (NASDAQ:SLS) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners